GSA Capital Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Buy |
12,876
+2,496
| +24% | +$41.9K | 0.02% | 1471 |
|
|
2025
Q1 | $160K | Buy |
+10,380
| New | +$160K | 0.01% | 1447 |
|
|
2022
Q1 | – | Sell |
-15,883
| Closed | -$127K | – | 1823 |
|
|
2021
Q4 | $127K | Buy |
+15,883
| New | +$127K | 0.02% | 1294 |
|
|
2020
Q3 | – | Sell |
-13,200
| Closed | -$163K | – | 1385 |
|
|
2020
Q2 | $163K | Buy |
+13,200
| New | +$163K | 0.09% | 399 |
|
|
2020
Q1 | – | Sell |
-15,805
| Closed | -$155K | – | 1539 |
|
|
2019
Q4 | $155K | Sell |
15,805
-5,563
| -26% | -$54.6K | 0.02% | 1304 |
|
|
2019
Q3 | $147K | Buy |
+21,368
| New | +$147K | 0.02% | 1229 |
|
|
2016
Q4 | – | Sell |
-15,322
| Closed | -$705K | – | 1956 |
|
|
2016
Q3 | $705K | Buy |
15,322
+10,913
| +248% | +$502K | 0.04% | 842 |
|
|
2016
Q2 | $221K | Sell |
4,409
-2,611
| -37% | -$131K | 0.01% | 1523 |
|
|
2016
Q1 | $376K | Buy |
+7,020
| New | +$376K | 0.02% | 1178 |
|
|
2015
Q3 | – | Sell |
-8,055
| Closed | -$476K | – | 2010 |
|
|
2015
Q2 | $476K | Buy |
+8,055
| New | +$476K | 0.02% | 1380 |
|
|
2014
Q3 | – | Sell |
-4,352
| Closed | -$228K | – | 1928 |
|
|
2014
Q2 | $228K | Buy |
+4,352
| New | +$228K | 0.01% | 1552 |
|